中国临床神经外科杂志

参考文献

[1]Hopkins K,Chandler C,Eatough J,et al.Direct injection of 90Y MoAbs into glioma tumor resection cavities leads to limited diffusion of the radioimmunoconjugates into normal brain parenchyma:a model to estimate absorbed radiation dose[J].Int J Radiat Oncol Biol Phys,1998,40(4):835844.

[2]Freije WA,Castro-Vargas FE,Fang Z,et al.Gene expression profiling of gliomas strongly predicts survival[J].Cancer Res,2004,64(18):6503-6510.

[3]Steinman RM,Cohn ZA.Identification of a novel cell type in peripheral lymphoid organs of mice.Ⅱ.Functional properties in vitro[J].J Exp Med,1974,139(2):380-397.

[4]Hart DN,Hill GR.Dendritic cell immunotherapy for cancer:application to low-grade lymphoma and multiple myeloma[J].Immunol Cell Biol,1999,77(5):451-459.

[5]Hsu FJ,Benike C,Fagnoni F,et al.Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells[J].Nat Med,1996,2(1):52-58.

[6]Liau LM,Black KL,Prins RM,et al.Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens[J].J Neurosurg,1999,90(6):11151124.

[7]Yu JS,Wheeler CJ,Zeltzer PM,et al.Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration[J].Cancer Res,2001,61(3):842-847.

[8]Holmes LM,Li J,Sticca RP,et al.A rapid,novel strategy to induce tumor cell-specific cytotoxic T lymphocyte responses using instant dendritomas[J].J Immunother(1991),2001,24(2):122-129.

[9]Albert ML,Jegathesan M,Darnell RB.Dendritic cell maturation is required for the cross-tolerization of CD8+T cells[J].Nat Immunol,2001,2(11):1010-1017.

[10]Akasaki Y,Kikuchi T,Homma S,et al.Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model[J].J Immunother,2001,24(2):106-113.

[11]Kikuchi T,Akasaki Y,Irie M,et al.Results of a phaseⅠclinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells[J].Cancer Immunol Immunother,2001,50(7):337-344.

[12]Yamanaka R,Abe T,Yajima N,et al.Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses:results of a clinical phaseⅠ/II trial[J].Br J Cancer,2003,89(7):1172-1179.

[13]俞建波,冯志仙,詹仁雅,等.RNA致敏树突状细胞治疗胶质瘤的实验研究[J].浙江大学学报(医学版),2007,(6):592-597.

[14]Belfrage H,Bhiladvala P,Hedlund G,et al.Combined activation of murine lymphocytes with staphylococcal enterotoxin and interleukin-2results in additive cytotoxic activity[J].Cancer Immunol Immunother,1994,38(4):265-271.

[15]Lespagnard L,Mettens P,Verheyden AM,et al.Dendritic cells fused with mastocytoma cells elicit therapeutic antitumor immunity[J].Int J Cancer,1998,76(2):250-258.

[16]Kawakami K,Takeshita F,Puri RK.Identification of distinct roles for a dileucine and a tyrosine internalization motif in the interleukin(IL)-13 binding component IL-13 receptor alpha2 chain[J].J Biol Chem,2001,276(27):2511425120.

[17]Kunwar S,Prados MD,Chang SM,et al.Direct intracerebral delivery of cintredekin besudotox(IL13-PE38QQR)in recurrent malignant glioma:a report by the Cintredekin Besudotox Intraparenchymal Study Group[J].J Clin Oncol,2007,25(7):837-844.

[18]杨群英,陈忠平.恶性胶质瘤分子靶向药物联合治疗新动态[J].中国神经肿瘤杂志,2007,5(4):273-278.

[19]Wen PY,Kesari S,Drappatz J.Malignant gliomas:strategies to increase the effectiveness of targeted molecular treatment[J].Expert Rev Anticancer Ther,2006,6(5):733-754.

[20]Guha A,Mukherjee J.Advances in the biology of astrocytomas[J].Curr Opin Neurol,2004,17(6):655-662.

[21]Savage DG,Antman KH.Imatinib mesylate--a new oral targeted therapy[J].N Engl J Med,2002,346(9):683-693.

[22]Scherr M,Morgan MA,Eder M.Gene silencing mediated by small interfering RNAs in mammalian cells[J].Curr Med Chem,2003,10(3):245-256.

[23]Nandi S,Ulasov IV,Tyler MA,et al.Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells[J].Cancer Res,2008,68(14):57785784.

[24]Guillard S,Clarke PA,Te Poele R,et al.Molecular pharmacology of phosphatidylinositol 3-kinase inhibition in human glioma[J].Cell Cycle,2009,8(3):443-453.

[25]王东海,李新钢,王英,等.DC/C6融合瘤苗防治C6胶质瘤的实验研究[J].中国病理生理杂志,2007,23(2):254-257.

[26]傅相平,张志文,易林华.(131)I肿瘤细胞核人鼠嵌合单抗脑胶质瘤瘤内放免治疗研究[J].中华实验外科杂志,2005,(1):103-104.

[27]Ignatova TN,Kukekov VG,Laywell ED,et al.Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro[J].Glia,2002,39(3):193-206.

[28]Nakamura K,Ito Y,Kawano Y,et al.Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model[J].Gene Ther,2004,11(14):1155-1164.

[29]高宝成,万锋,陈坚,等.侧群细胞分析法在脑肿瘤干细胞研究中的应用及其局限性[J].中国现代神经疾病杂志,2009,9(6):535-538.

[30]Wan F,Zhang S,Xie R,et al.The utility and limitations of neurosphere assay,CD133 immunophenotyping and side population assay in glioma stem cell research[J].Brain Pathol,2010.